|
US6740682B2
(en)
|
1997-08-29 |
2004-05-25 |
Tularik Limited |
Meta-benzamidine derivatives as serine protease inhibitors
|
|
WO2000047553A2
(en)
*
|
1999-02-11 |
2000-08-17 |
Cor Therapeutics Inc. |
ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
|
|
DE10012732A1
(de)
|
2000-03-18 |
2001-09-20 |
Aventis Behring Gmbh |
Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
|
|
SE0001803D0
(sv)
|
2000-05-16 |
2000-05-16 |
Astrazeneca Ab |
New compounds i
|
|
GB0108903D0
(en)
*
|
2000-10-05 |
2001-05-30 |
Aventis Pharm Prod Inc |
Novel crystalline forms of a factor Xa inhibitor
|
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
HU230253B1
(hu)
|
2001-01-26 |
2015-11-30 |
Merck Sharp & Dohme Corp |
Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
|
|
US7071181B2
(en)
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
|
DK1355644T3
(da)
|
2001-01-26 |
2006-10-23 |
Schering Corp |
Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
|
|
US20020183519A1
(en)
*
|
2001-03-13 |
2002-12-05 |
Herbert Nar |
Antithrombotic carboxylic acid amides
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
JP2005504091A
(ja)
|
2001-09-21 |
2005-02-10 |
シェーリング コーポレイション |
ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
|
|
GB0124936D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124934D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124933D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124941D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124931D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124938D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124939D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
ATE375980T1
(de)
|
2002-02-12 |
2007-11-15 |
Smithkline Beecham Corp |
Nicotinamide und deren verwendung als p38 inhibitoren
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1394159A1
(fr)
*
|
2002-08-13 |
2004-03-03 |
Warner-Lambert Company LLC |
Nouveaux dérivés de thiophène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
|
|
WO2004043457A1
(en)
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
|
|
AU2003302238A1
(en)
|
2002-12-03 |
2004-06-23 |
Axys Pharmaceuticals, Inc. |
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
|
|
GB0230162D0
(en)
*
|
2002-12-24 |
2003-02-05 |
Metris Therapeutics Ltd |
Compounds useful in inhibiting angiogenesis
|
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
CA2517571C
(en)
|
2003-03-07 |
2011-07-05 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
JP4589919B2
(ja)
|
2003-03-07 |
2010-12-01 |
シェーリング コーポレイション |
高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
|
|
JP2006519869A
(ja)
*
|
2003-03-07 |
2006-08-31 |
シェーリング コーポレイション |
置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
|
|
GB0308185D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
WO2005033079A1
(ja)
*
|
2003-09-30 |
2005-04-14 |
Eisai Co., Ltd. |
ヘテロ環化合物を含有する新規な抗真菌剤
|
|
GB0402143D0
(en)
*
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
|
WO2005095386A1
(en)
*
|
2004-03-30 |
2005-10-13 |
Chiron Corporation |
Substituted thiophene derivatives as anti-cancer agents
|
|
US20050241110A1
(en)
*
|
2004-04-09 |
2005-11-03 |
Bruce Baker |
Ergonomic handles, especially for garden tools
|
|
US7563780B1
(en)
*
|
2004-06-18 |
2009-07-21 |
Advanced Cardiovascular Systems, Inc. |
Heparin prodrugs and drug delivery stents formed therefrom
|
|
US20090227799A1
(en)
*
|
2004-08-09 |
2009-09-10 |
Kazutaka Nakamoto |
Novel Antimalarial Agent Containing Heterocyclic Compound
|
|
US20080051416A1
(en)
*
|
2004-10-05 |
2008-02-28 |
Smithkline Beecham Corporation |
Novel Compounds
|
|
EP1864980A4
(en)
|
2005-03-30 |
2010-08-18 |
Eisai R&D Man Co Ltd |
A PYRIDINE DERIVATIVE ANTIPILIC AGENT
|
|
GB0512429D0
(en)
*
|
2005-06-17 |
2005-07-27 |
Smithkline Beecham Corp |
Novel compound
|
|
TWI385169B
(zh)
*
|
2005-10-31 |
2013-02-11 |
Eisai R&D Man Co Ltd |
經雜環取代之吡啶衍生物及含有彼之抗真菌劑
|
|
PL3357911T3
(pl)
|
2006-06-26 |
2022-09-05 |
Akebia Therapeutics Inc. |
Inhibitory prolilohydroksylazy i sposoby ich użycia
|
|
EP2065377B1
(en)
*
|
2006-09-21 |
2011-11-23 |
Eisai R&D Management Co., Ltd. |
Pyridine derivative substituted by heteroaryl ring, and antifungal agent comprising the same
|
|
WO2008136279A1
(ja)
*
|
2007-04-27 |
2008-11-13 |
Eisai R & D Management Co., Ltd. |
ヘテロ環置換ピリジン誘導体の塩またはその結晶
|
|
TW200841879A
(en)
*
|
2007-04-27 |
2008-11-01 |
Eisai R&D Man Co Ltd |
Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same
|
|
US8513287B2
(en)
|
2007-12-27 |
2013-08-20 |
Eisai R&D Management Co., Ltd. |
Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
|
|
US8188119B2
(en)
*
|
2008-10-24 |
2012-05-29 |
Eisai R&D Management Co., Ltd |
Pyridine derivatives substituted with heterocyclic ring and γ-glutamylamino group, and antifungal agents containing same
|
|
GB0919194D0
(en)
|
2009-11-02 |
2009-12-16 |
Lytix Biopharma As |
Compounds
|
|
EP2496578A4
(en)
|
2009-11-05 |
2013-08-21 |
Univ Notre Dame Du Lac |
IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
|
|
CA2793086C
(en)
*
|
2010-03-18 |
2018-08-21 |
Institut Pasteur Korea |
Substituted imidazo[1,2-a]pyridine compounds and their use in the treatment of bacterial infections
|
|
JP5993933B2
(ja)
|
2011-03-29 |
2016-09-14 |
サノフイ |
安定性を改善したオタミキサバン製剤
|
|
RU2597423C2
(ru)
*
|
2011-03-29 |
2016-09-10 |
Санофи |
Бензойнокислая соль отамиксабана
|
|
MY169319A
(en)
|
2011-07-26 |
2019-03-21 |
Sanofi Sa |
3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
|
|
EP2759533B1
(en)
|
2011-09-22 |
2017-08-02 |
Takeda Pharmaceutical Company Limited |
Condensed heterocyclic compound
|
|
CN108348510B
(zh)
|
2015-09-17 |
2022-01-04 |
圣母大学 |
针对分枝杆菌感染有用的含有苄胺的杂环化合物以及组合物
|